Risk factor
Moderate default risk
Profitability factor
Very favourable analyst view
In Guru Portfolios
Portfolio Weight (%)
Change
Fund
Portfolio Weight (%)
Change
Fund
Portfolio Weight (%)
Change
Fund
Manager | Fund | Portfolio Weight (%) | Change |
|---|---|---|---|
Data is available to registered users only | Data is available to registered users only | Data is available to registered users only | Data is available to registered users only |
Data is available to registered users only | Data is available to registered users only | Data is available to registered users only | Data is available to registered users only |
Data is available to registered users only | Data is available to registered users only | Data is available to registered users only | Data is available to registered users only |
About
Nature's Sunshine Products, Inc. is a natural health and wellness enterprise that primarily manufactures and distributes a wide array of nutritional supplements and personal care products. The company's operational reach spans several continents, including Asia, Europe, North America, and Latin America. Its comprehensive nutritional offerings cater to general well-being, providing support for blood sugar regulation, bone density, cellular vitality, cognitive sharpness, joint mobility, mood balance, sexual wellness, sleep quality, athletic performance, and visual acuity. Additionally, it supplies specialized products for immune support, cardiovascular health, and digestive function, alongside solutions for weight management. In the personal care segment, their product line includes items such as essential oils and lotions, aloe vera gels, botanical shampoos, herbal skin treatments, dental care products like toothpaste, and skin cleansing formulations. These goods are sold under the company's proprietary Nature's Sunshine and Synergy WorldWide brands, primarily through an extensive network of independent sales consultants. Established in 1972, the organization is headquartered in Lehi, Utah.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITD
Target Price
The average target price of NATR is 34.0 and suggests 66% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa